Surrogate Markers of Portal Pressure
Public ClinicalTrials.gov record NCT02508298. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Surrogate Markers of Portal Pressure and Changes in Portal Pressure in Patients With Compensated Cirrhosis Undergoing Anti-viral Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a prospective longitudinal study that will evaluate if changes (pre and post therapy) in indocyanine green (ICG) retention test and liver stiff ness (LS) and spleen stiffness (SS) as measured by acoustic radiofrequency impulse (ARFI) correlate with changes in portal pressure as determined by the hepatic vein pressure gradient (HVPG) in patients with compensated hepatitis C virus (HCV) cirrhosis undergoing antiviral therapy.
Study identification
- NCT ID
- NCT02508298
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 41 participants
Conditions and interventions
Conditions
Interventions
- HVPG Procedure
- Indocyanine Green Retention test Drug
- Liver stiffness measurement Device
- Spleen stiffness measurement Device
Procedure · Drug · Device
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2014
- Primary completion
- Jun 30, 2018
- Completion
- Jun 30, 2019
- Last update posted
- Nov 24, 2019
2014 – 2019
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Yale-New Haven Hospital | New Haven | Connecticut | 06511 | — |
| VA Connecticut Healthcare System | West Haven | Connecticut | 06516 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Portal Hypertension trials
Other public records listing Portal Hypertension. Sorted by last update posted; newest first. Not a recommendation.
- NCT07140120: LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary Study Active, not recruiting
- NCT05711316: The BD Liverty™ TIPS Stent Graft Study Active, not recruiting
- NCT06797193: Ultrasound With Subharmonic Imaging and Subharmonic Aided Pressure Estimation (SHAPE) to Identify Portal Hypertension Recruiting
- NCT06265272: Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis Recruiting
- NCT05470205: Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02508298, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 24, 2019 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02508298 live on ClinicalTrials.gov.